Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
59.32
-1.36 (-2.24%)
Official Closing Price
Updated: 4:10 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
30,466,975
Open
60.01
Bid (Size)
59.50 (200)
Ask (Size)
59.52 (400)
Prev. Close
60.68
Today's Range
57.56 - 60.17
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
1.97%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Arctic Ultimatum: Trump’s Greenland Tariff Threat Triggers $4,700 Gold Surge and 870-Point Dow Plunge
Today 14:02 EST
The global financial landscape was thrown into chaos on January 20, 2026, as President Donald Trump intensified his administration’s pursuit of Greenland, issuing a sweeping tariff ultimatum against...
Via
MarketMinute
Topics
Economy
Government
Stocks
2 Top Stocks to Double Up On Right Now
↗
January 20, 2026
When you find winning stocks, stick with them.
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
+13.2%
+13.2%
1 Month
+23.3%
+23.3%
3 Month
+8.3%
+8.3%
6 Month
-11.2%
-11.2%
1 Year
-26.8%
-26.8%
More News
Read More
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic
↗
January 20, 2026
Via
Stocktwits
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Demonstrates a Strong Dividend Profile Backed by High Profitability
↗
January 19, 2026
Via
Chartmill
NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’
↗
January 16, 2026
Via
Stocktwits
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly
↗
January 14, 2026
Via
Stocktwits
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals
↗
January 14, 2026
Via
Stocktwits
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
↗
January 20, 2026
Via
The Motley Fool
Is Oral Wegovy a Game Changer for Novo Nordisk?
↗
January 20, 2026
Via
The Motley Fool
Arctic Chill: Global Markets Reeling as Trump Demands Greenland Purchase with Massive Tariff Threats
January 20, 2026
Via
MarketMinute
Topics
Economy
Government
Stocks
The Arctic Gambit: Trump’s National Security Push for Greenland Sparks Diplomatic Crisis and Market Volatility
January 19, 2026
Via
MarketMinute
Topics
Economy
Electric Vehicles
Government
The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
↗
January 19, 2026
Via
MarketBeat
Topics
ETFs
Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
January 19, 2026
Via
Finterra
Topics
Economy
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
January 19, 2026
Via
Finterra
Topics
Artificial Intelligence
Bankruptcy
Economy
Prediction: 2026 Will Be the Year of Eli Lilly
↗
January 19, 2026
Via
The Motley Fool
The Arctic Ultimatums: Trump’s Greenland Bid Sparks Global Trade War and NATO Crisis
January 16, 2026
Via
MarketMinute
Topics
Economy
Government
World Trade
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy?
↗
January 16, 2026
Via
The Motley Fool
NVO Stock Is Rising Pre-Market – What Is The Wegovy News Driving Novo Nordisk Shares?
↗
January 16, 2026
Via
Stocktwits
Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit
↗
January 15, 2026
Via
Benzinga
Topics
Lawsuit
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
January 15, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers
↗
January 15, 2026
Via
Benzinga
Topics
Lawsuit
Slimmer Waistlines, Fatter Margins: Jefferies Says Airline Companies Will Profit From America’s Weight-Loss Boom
↗
January 14, 2026
Via
Stocktwits
Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
January 14, 2026
Via
MarketMinute
Topics
Earnings
Economy
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 59.32
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/21/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.